Publications

Technology Status Evaluation Reports

Technology status evaluation reports provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Reports are based on an evaluation of medical literature and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided. Technology status evaluation reports are scientific reviews based on expert consensus and are provided solely for educational and informational purposes.

The members of the 91ÊÓƵTechnology Committee provide ongoing conflict of interest (COI) disclosures throughout the development and publication of all documents in accordance with the 91ÊÓƵPolicy for Managing Declared Conflicts of Interests.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published

  • Gastrointest Endosc 2025; Volume 101, Issue 3; P496-510 DOI: 10.1016/j.gie.2024.06.038

  • Gastrointest Endosc 2024; Volume 100, Issue 6; P980-993 DOI: 10.1016/j.gie.2024.05.004

  • Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P226-239

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • iGIE 2023; Volume 2, Issue 2; P254-261
Upper Endoscopy
All assessments
RETs
PIVIs

  • Gastrointest Endosc 2025; Volume 101, Issue 3; P496-510 DOI: 10.1016/j.gie.2024.06.038

  • Gastrointest Endosc 2024; Volume 100, Issue 6; P980-993 DOI: 10.1016/j.gie.2024.05.004

  • Video GIE 2022; Volume 7, Issue 1; P1-20

  • Gastrointest Endosc 2021; Volume 94, Issue 4; P671-684

  • Gastrointest Endosc 2021; Volume 94, Issue 1; P3-13

  • Video GIE 2020; Volume 5, Issue 12; P598-613

  • Gastrointest Endosc Sept 2020, Volume 92, Issue 3, Pages 483-491 / DOI:

  • GIE 2019; Volume 90, Issue 3; P325-334

  • Gastrointest Endosc July 2019 Volume 90, Issue 1, Pages 27–34

  • Gastrointest Endosc July 2019 Volume 90, Issue 1, Pages 13–26

  • Endoscopic anti-reflux devices (with videos) 2017

    Gastrointest Endosc 2017; Volume 86, Issue 6; P931-948

  • Gastrointest Endosc 2016;83:1051–1060

  • Gastrointest Endosc 2016;83:684–698.e7

  • Gastrointest Endosc 2015;82:215–226

  • Gastrointest Endosc 2015;82:975-990

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Colonoscopy
All assessments
PIVIs

  • Gastrointest Endosc 2021; Volume 94, Issue 1; P1-2

  • Volume 92, Issue 3, Pages 474-482

  • Gastrointest Endosc March 2018 Volume 87, Issue 3, Pages 625–634

  • Gastrointest Endosc 2015;81:1122–1129

  • Gastrointest Endosc 2015;81:502.e1–502.e16

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Bariatric Endoscopy
All assessments
RETs
PIVIs

  • Gastrointest Endosc Sept 2020, Volume 92, Issue 3, Pages 492-507 / DOI

  • Gastrointest Endosc 2015;82:425–438.e5

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
ERCP

  • VideoGIE 2018;3:329-338

  • Gastrointest Endosc 2016;84:209–221

  • Gastrointest Endosc 2016;83:1061–1075
EUS
All assessments
RETs

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: 91ÊÓƵTechnology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, F91ÊÓƵ, Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, F91ÊÓƵ, Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, F91ÊÓƵ(Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Endoscope Design/Reprocessing
All assessments 
RETs

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • Gastrointest Endosc 2021; Volume 94, Issue 3; P457-470

  • Gastrointest Endosc 2021; Volume 93, Issue 5; P997-1005

  • GIE 2019; Volume 90, Issue 1; P1-12

  • Gastrointest Endosc 2016;84:885–892

  • Gastrointest Endosc 2016;83:857–865

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • Gastrointest Endosc 2021; Volume 93, Issue 5; P997-1005
Other Imaging Techniques
All assessments
RETs

  • Gastrointest Endosc 2021; Volume 93, Issue 4; P784-796

  • Gastrointest Endosc 2015;81:249–261
Therapeutic GI Devices
All assessments
RETs

  • iGIE 2023; Volume 2, Issue 2; P226-239

  • Video GIE 2019; Volume 4, Issue 8; P343-350

  • Video GIE 2019; Volume 4, Issue 7; P285-299

  • VideoGIE October 2017 Volume 2, Issue 10, Pages 252–259

  • VideoGIE May 2017, Volume 2, Issue 5, Pages 89–95

  • Gastrointest Endosc 2015;81:1311–1325

  • iGIE 2023; Volume 2, Issue 2; P226-239
Miscellaneous
All assessments
RETs

Submucosal injection fluid and tattoo agents 2024

Nov 5, 2024, 11:24
Title : Submucosal injection fluid and tattoo agents 2024
URL :
Doi org link : https://www.giejournal.org/article/S0016-5107(24)03347-9/fulltext
Volume : Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002
Select a choice : Keep
Content created :
ExternalPK :
File size :
Categories :
Tags :
  • misc

  • Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002

  • iGIE 2023; Volume 2, Issue 2; P254-261

In Progress Technology Assessments

Endoscopic closure devices

2025

iStock-1189305225(1)

Practice Guidelines

View all